Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Ocumension Therapeutics, a leading ophthalmic pharmaceutical platform company with a focus on first-in-class or best-in-class ophthalmic therapies, has started book building to raise up to USD 200 m to list in Hong Kong. While the majority of the Chapter 18A IPOs has a focus on innovative oncology drugs, this company is unique in the sense that it has a long list of ophthalmology drugs in the late stage of development. The company's assets cover major eye diseases (cataracts, glaucoma, age-rela...
Ocumension Therapeutics, a leading ophthalmic pharmaceutical platform company with a focus on first-in-class or best-in-class ophthalmic therapies, aims to raise up to USD 300 million via a Hong Kong listing. While the majority of the Chapter 18A IPOs has a focus on innovative oncology drugs, this company is unique in the sense that it has a long list of ophthalmology drugs in the late stage of development. The company's assets cover major eye diseases (cataracts, glaucoma, age-related macular ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.